[go: up one dir, main page]

SE9904765D0 - Pharmaceutically-useful compounds - Google Patents

Pharmaceutically-useful compounds

Info

Publication number
SE9904765D0
SE9904765D0 SE9904765A SE9904765A SE9904765D0 SE 9904765 D0 SE9904765 D0 SE 9904765D0 SE 9904765 A SE9904765 A SE 9904765A SE 9904765 A SE9904765 A SE 9904765A SE 9904765 D0 SE9904765 D0 SE 9904765D0
Authority
SE
Sweden
Prior art keywords
pharmaceutically useful
useful compounds
compounds
arrhythmias
pharmaceutically
Prior art date
Application number
SE9904765A
Other languages
English (en)
Swedish (sv)
Inventor
Magnus Bjoersne
Fritiof Ponten
Gert Strandlund
Peder Svensson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9904765A priority Critical patent/SE9904765D0/xx
Publication of SE9904765D0 publication Critical patent/SE9904765D0/xx
Priority to ARP000106579A priority patent/AR026925A1/es
Priority to CO00095911A priority patent/CO5261611A1/es
Priority to NZ519497A priority patent/NZ519497A/en
Priority to US09/763,892 priority patent/US6559162B2/en
Priority to AU25659/01A priority patent/AU777069B2/en
Priority to JP2001549365A priority patent/JP2003519128A/ja
Priority to EP00989114A priority patent/EP1244631A1/en
Priority to BR0016678-2A priority patent/BR0016678A/pt
Priority to KR1020027008151A priority patent/KR20020063261A/ko
Priority to CZ20022174A priority patent/CZ20022174A3/cs
Priority to EEP200200305A priority patent/EE200200305A/xx
Priority to UA2002064618A priority patent/UA75057C2/uk
Priority to SK891-2002A priority patent/SK8912002A3/sk
Priority to HU0301030A priority patent/HUP0301030A3/hu
Priority to RU2002114821/04A priority patent/RU2262505C2/ru
Priority to CA002394097A priority patent/CA2394097A1/en
Priority to PCT/SE2000/002604 priority patent/WO2001047893A1/en
Priority to MXPA02006249A priority patent/MXPA02006249A/es
Priority to CNB008190860A priority patent/CN1229350C/zh
Priority to PL00357098A priority patent/PL357098A1/xx
Priority to IL15021200A priority patent/IL150212A0/xx
Priority to MYPI20006092A priority patent/MY133785A/en
Priority to ZA200204310A priority patent/ZA200204310B/en
Priority to IS6438A priority patent/IS6438A/is
Priority to NO20023038A priority patent/NO20023038L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/24—Camphidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE9904765A 1999-12-23 1999-12-23 Pharmaceutically-useful compounds SE9904765D0 (sv)

Priority Applications (26)

Application Number Priority Date Filing Date Title
SE9904765A SE9904765D0 (sv) 1999-12-23 1999-12-23 Pharmaceutically-useful compounds
ARP000106579A AR026925A1 (es) 1999-12-23 2000-12-12 Nuevos derivados de azabiciclooctano utiles en el tratamiento de arritmias cardiacas
CO00095911A CO5261611A1 (es) 1999-12-23 2000-12-18 Nuevos derivados azabibiclooctano utiles en el tratamiento de arritmias cardiacas
IL15021200A IL150212A0 (en) 1999-12-23 2000-12-19 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
UA2002064618A UA75057C2 (en) 1999-12-23 2000-12-19 Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias, a method for obtaining thereof (variants), pharmaceutical composition based thereon and intermediary compound
HU0301030A HUP0301030A3 (en) 1999-12-23 2000-12-19 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias, process for their preparation and pharmaceutical compositions containing them
AU25659/01A AU777069B2 (en) 1999-12-23 2000-12-19 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
JP2001549365A JP2003519128A (ja) 1999-12-23 2000-12-19 心不整脈の処置に有用な新規アザビシクロオクタン誘導体
EP00989114A EP1244631A1 (en) 1999-12-23 2000-12-19 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
BR0016678-2A BR0016678A (pt) 1999-12-23 2000-12-19 Composto, formulação farmacêutica, uso de um composto, método para profilaxia ou tratamento de uma arritmia, e, processo para preparação de um composto
KR1020027008151A KR20020063261A (ko) 1999-12-23 2000-12-19 심부정맥의 치료에 유용한 신규 아자비시클로옥탄 유도체
CZ20022174A CZ20022174A3 (cs) 1999-12-23 2000-12-19 Azabicyklooktanové deriváty, farmaceutický prostředek je obsahující a způsob a meziprodukty pro jejich přípravu
EEP200200305A EE200200305A (et) 1999-12-23 2000-12-19 Südame arütmiate ravis kasutatavad uued asabitsüklooktaani derivaadid
NZ519497A NZ519497A (en) 1999-12-23 2000-12-19 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
SK891-2002A SK8912002A3 (en) 1999-12-23 2000-12-19 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
US09/763,892 US6559162B2 (en) 1999-12-23 2000-12-19 Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
RU2002114821/04A RU2262505C2 (ru) 1999-12-23 2000-12-19 Производные азабициклооктана, фармацевтические препараты, способ профилактики или лечения, способы получения соединений, соединения
CA002394097A CA2394097A1 (en) 1999-12-23 2000-12-19 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
PCT/SE2000/002604 WO2001047893A1 (en) 1999-12-23 2000-12-19 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
MXPA02006249A MXPA02006249A (es) 1999-12-23 2000-12-19 Nuevos derivados de azabiciclooctano, utiles en el tratamiento de arritmias cardiacas.
CNB008190860A CN1229350C (zh) 1999-12-23 2000-12-19 用于治疗心律失常的新的氮杂双环辛烷衍生物
PL00357098A PL357098A1 (en) 1999-12-23 2000-12-19 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
MYPI20006092A MY133785A (en) 1999-12-23 2000-12-21 Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
ZA200204310A ZA200204310B (en) 1999-12-23 2002-05-29 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias.
IS6438A IS6438A (is) 1999-12-23 2002-06-20 Nýjar asabísýklóoktanafleiður sem eru gagnlegar við meðhöndlun á hjartsláttartruflunum
NO20023038A NO20023038L (no) 1999-12-23 2002-06-21 Nye azabicyklooktanderivater for anvendelse ved behandling av kardiale arytmier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904765A SE9904765D0 (sv) 1999-12-23 1999-12-23 Pharmaceutically-useful compounds

Publications (1)

Publication Number Publication Date
SE9904765D0 true SE9904765D0 (sv) 1999-12-23

Family

ID=20418291

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9904765A SE9904765D0 (sv) 1999-12-23 1999-12-23 Pharmaceutically-useful compounds

Country Status (26)

Country Link
US (1) US6559162B2 (xx)
EP (1) EP1244631A1 (xx)
JP (1) JP2003519128A (xx)
KR (1) KR20020063261A (xx)
CN (1) CN1229350C (xx)
AR (1) AR026925A1 (xx)
AU (1) AU777069B2 (xx)
BR (1) BR0016678A (xx)
CA (1) CA2394097A1 (xx)
CO (1) CO5261611A1 (xx)
CZ (1) CZ20022174A3 (xx)
EE (1) EE200200305A (xx)
HU (1) HUP0301030A3 (xx)
IL (1) IL150212A0 (xx)
IS (1) IS6438A (xx)
MX (1) MXPA02006249A (xx)
MY (1) MY133785A (xx)
NO (1) NO20023038L (xx)
NZ (1) NZ519497A (xx)
PL (1) PL357098A1 (xx)
RU (1) RU2262505C2 (xx)
SE (1) SE9904765D0 (xx)
SK (1) SK8912002A3 (xx)
UA (1) UA75057C2 (xx)
WO (1) WO2001047893A1 (xx)
ZA (1) ZA200204310B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
JP2003528076A (ja) * 2000-03-20 2003-09-24 メルク シャープ エンド ドーム リミテッド スルホンアミド置換架橋ビシクロアルキル誘導体
DE60203623T2 (de) * 2001-07-19 2006-01-19 CV Therapeutics, Inc., Palo Alto Substituierte piperazinderivate und ihre verwendung als fettsaüre-oxidationsinhibitoren
US7001909B2 (en) * 2001-07-19 2006-02-21 Cv Therapeutics, Inc. Substituted heterocyclic compounds
BR0215801A (pt) 2002-07-08 2005-05-10 Ranbaxy Lab Ltd Derivados de 3,6-dissubstituìdos azabiciclo [3.1.0] hexano úteis como antagonistas de receptores muscarìnicos
US7056924B2 (en) * 2002-07-18 2006-06-06 Cv Therapeutics, Inc. Substituted heterocyclic compounds
US7488748B2 (en) * 2003-01-28 2009-02-10 Ranbaxy Laboratories Limited 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
US7517905B2 (en) 2003-04-09 2009-04-14 Ranbaxy Laboratories Limited Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
EA009387B1 (ru) 2003-04-11 2007-12-28 Рэнбакси Лабораториз Лимитед Азабициклические производные в качестве антагонистов мускаринового рецептора
CA2530376A1 (en) * 2003-06-23 2005-01-06 Cv Therapeutics, Inc. Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors
EP1797040A1 (en) * 2004-09-29 2007-06-20 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
JP4999061B2 (ja) * 2006-10-11 2012-08-15 日本曹達株式会社 ピペリジン−４−オン誘導体の製造方法
JP4994772B2 (ja) * 2006-10-11 2012-08-08 日本曹達株式会社 ビスアミノールエーテル化合物を用いるピペリジン−４−オン誘導体の製造方法
TW200911768A (en) * 2007-05-17 2009-03-16 Cortex Pharma Inc Di-substituted amides for enhancing glutamatergic synaptic responses
CN102311439B (zh) * 2010-07-02 2015-11-25 上海药明康德新药开发有限公司 1-取代-3，8-二氮杂双环[3.2.1]辛烷衍生物及制备方法
CN102452981B (zh) * 2010-11-03 2015-08-19 上海药明康德新药开发有限公司 1,3-二取代-3-氮杂双环[3.2.1]辛烷衍生物及制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2428792A1 (de) 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
DE3112055A1 (de) 1981-03-27 1982-10-07 Basf Ag, 6700 Ludwigshafen Bispidinderivate, ihre herstellung und diese enthaltende arzneimittel
DE3234697A1 (de) 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
GB8516371D0 (en) * 1985-06-28 1985-07-31 Beecham Group Plc Compounds
PT88381B (pt) 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
DE3732094A1 (de) 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
US5070094A (en) 1989-09-05 1991-12-03 G. D. Searle & Co. N-benzyltropaneamides
US5110933A (en) 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
US5084572A (en) * 1989-11-13 1992-01-28 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo [3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
FR2707986B1 (fr) 1993-07-22 1996-02-23 Smithkline Beecham Labo Pharma Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.
JP3235913B2 (ja) * 1993-07-30 2001-12-04 エーザイ株式会社 アミノ安息香酸誘導体
US5468858A (en) 1993-10-28 1995-11-21 The Board Of Regents Of Oklahoma State University Physical Sciences N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents
DE4402931A1 (de) 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Phenylsulfonyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel
CA2250372C (en) 1996-03-29 2005-06-21 Pfizer Inc. 6-phenylpyridyl-2-amine derivatives
PL333079A1 (en) 1996-10-30 1999-11-08 Schering Corp Piparazinic derivatives as antagonists of neurokinin
SE9704709D0 (sv) 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
TR200102911T2 (tr) 1999-04-09 2002-01-21 Astrazeneca Ab Adamantan türevleri.
SE9901875D0 (sv) 1999-05-25 1999-05-25 Astra Pharma Prod Novel compounds

Also Published As

Publication number Publication date
IL150212A0 (en) 2002-12-01
CA2394097A1 (en) 2001-07-05
US20020137766A1 (en) 2002-09-26
PL357098A1 (en) 2004-07-12
EE200200305A (et) 2003-06-16
KR20020063261A (ko) 2002-08-01
AR026925A1 (es) 2003-03-05
SK8912002A3 (en) 2003-02-04
NO20023038D0 (no) 2002-06-21
AU2565901A (en) 2001-07-09
HUP0301030A2 (hu) 2003-08-28
RU2002114821A (ru) 2004-01-20
WO2001047893A1 (en) 2001-07-05
BR0016678A (pt) 2002-10-15
US6559162B2 (en) 2003-05-06
MY133785A (en) 2007-11-30
CN1434802A (zh) 2003-08-06
NZ519497A (en) 2004-02-27
CZ20022174A3 (cs) 2002-09-11
JP2003519128A (ja) 2003-06-17
MXPA02006249A (es) 2004-09-06
UA75057C2 (en) 2006-03-15
IS6438A (is) 2002-06-20
HUP0301030A3 (en) 2007-03-28
CO5261611A1 (es) 2003-03-31
CN1229350C (zh) 2005-11-30
ZA200204310B (en) 2003-08-29
EP1244631A1 (en) 2002-10-02
RU2262505C2 (ru) 2005-10-20
NO20023038L (no) 2002-08-22
AU777069B2 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
SE9900100D0 (sv) New compounds
SE9704709D0 (sv) Pharmaceutically active compounds
SE9904765D0 (sv) Pharmaceutically-useful compounds
DK1204654T3 (da) Benzofurylpiperaziner og benzofurylhomopiperaziner: Serotonin agonister
ES2187473T3 (es) Triarylimidazoles.
JO2256B1 (en) Renin inhibitors
AP2002002637A0 (en) Novel piperazine
GEP20063920B (en) Alpha-(n-sulphonamido) acetamide derivatives as beta-amyloid inhibitors
NO20021811D0 (no) Nye oksabispidinforbindelser som er nyttige i behandlingen av hjertearrytmier
ATE495187T1 (de) Dalda-analoge und ihre verwendung
SE0104248D0 (sv) Method of treatment
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
DK1204659T3 (da) Serotonerge benzofuraner
MXPA02002838A (es) Derivados de piperazina sustituidos, su obtencion y uso como medicamentos.
SE0003795D0 (sv) Pharmaceutically useful compounds
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
NZ511997A (en) Isonipecotamides for the treatment of integrin-mediated disorders
SE9902268D0 (sv) Pharmaceutically active compounds
SE9902270D0 (sv) Pharmaceutically active compounds
HK1042090A1 (zh) N-取代的具有5-羟色胺能活性的酰亚胺衍生物
NO20042729L (no) Heksasykliske forbindelser
SE9901901D0 (sv) Compounds
SE9902271D0 (sv) Pharmaceutically active compounds
SE0401540D0 (sv) New compounds